T-group (topology)
315.1.1 Tautomerase/MIF
Ligands and drugs
1,528
Member domains
762
with ligand contacts (≤ 4 Å)
49.9% of members
649
with DrugDomain annotations
42.5% of members
542
with a DrugBank compound
35.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 315.1.1 belongs to X-group 315 Tautomerase/MIF-like, which binds 10.2 ligand superclasses per 20 proteins, broader than 95% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02175 | MLA | Malonic acid | 12 |
| DB03688 | 3OH | Hydracrylic acid | 12 |
| DB07718 | ENO | 4-Hydroxyphenylpyruvic acid | 8 |
| DB02384 | FHC | (E)-2-Fluoro-P-Hydroxycinnamate | 7 |
| DB09459 | TLA | L-tartaric acid | 6 |
| DB02005 | OXP | 2-Oxo-3-Pentenoic Acid | 5 |
| DB03350 | NCO | Cobalt hexammine ion | 5 |
| DB00695 | FUN | Furosemide | 3 |
| DB01148 | HWL | Flavoxate | 3 |
| DB02375 | MYC | Myricetin | 3 |
| DB02676 | B3P | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | 3 |
| DB02728 | YZ9 | 7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester | 3 |
| DB03297 | PMS | Benzylsulfonic acid | 3 |
| DB07888 | HDI | 3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER | 3 |
| DB08333 | OX3 | 4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME | 3 |
| DB08334 | OX4 | 3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME | 3 |
| DB08335 | OX5 | 4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME | 3 |
| DB08765 | ZEC | 6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE | 3 |
| DB00142 | GLU | Glutamic acid | 2 |
| DB01880 | DHC | 3,4-Dihydroxycinnamic Acid | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 103 |
| NAmetal | SODIUM ION | 30 |
| 7DH | (3E)-5-hydroxy-2-oxopent-3-enoic acid | 17 |
| 6Y5 | 5-fluoranyl-2-oxidanylidene-pentanoic acid | 15 |
| 3OH | 3-HYDROXY-PROPANOIC ACID | 14 |
| 3TX | 4-[4-(quinolin-2-yl)-1H-1,2,3-triazol-1-yl]phenol | 12 |
| ENO | 3-(4-HYDROXY-PHENYL)PYRUVIC ACID | 12 |
| MLA | MALONIC ACID | 12 |
| PR6 | 3-chloro-3-oxopropanoic acid | 10 |
| RW1 | 4-phenylpyrimidine | 10 |
| A1BXY | prop-2-ynoic acid | 9 |
| EN1 | (2E)-2-hydroxy-3-(4-hydroxyphenyl)prop-2-enoic acid | 9 |
| ZNmetal | ZINC ION | 8 |
| A1AWY | 3-bromo-3-oxopropanoic acid | 7 |
| FHC | 2-FLUORO-3-(4-HYDROXYPHENYL)-2E-PROPENEOATE | 7 |
| 9BE | N-benzylthioformamide | 6 |
| A1IZH | (1~{Z},2~{S})-1-[(~{E})-3-(2-hydroxyphenyl)prop-2-enylidene]-1$l^{4}-azolidine-2-carbaldehyde | 6 |
| AVR | (2R)-2-amino-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one | 6 |
| LE2 | N-(2-phenylethyl)thioformamide | 6 |
| TLA | L(+)-TARTARIC ACID | 6 |